284 related articles for article (PubMed ID: 22627470)
1. Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty.
Bander J; Elmariah S; Aledort LM; Dlott J; Stelzer P; Halperin JL; Kini AS; Sharma SK
Thromb Haemost; 2012 Jul; 108(1):86-93. PubMed ID: 22627470
[TBL] [Abstract][Full Text] [Related]
2. Beneficial Effects of High-Density Lipoproteins on Acquired von Willebrand Syndrome in Aortic Valve Stenosis.
Gebhard C; Maafi F; Stähli BE; Bonnefoy A; Gebhard CE; Nachar W; de Oliveira Moraes AB; Mecteau M; Mihalache-Avram T; Lavoie V; Kernaleguen AE; Shi Y; Busseuil D; Chabot-Blanchet M; Perrault LP; Rhainds D; Rhéaume E; Tardif JC
Thromb Haemost; 2018 Feb; 118(2):288-297. PubMed ID: 29443370
[TBL] [Abstract][Full Text] [Related]
3. von Willebrand Factor Abnormalities and Heyde Syndrome in Dysfunctional Heart Valve Prostheses.
Blackshear JL; McRee CW; Safford RE; Pollak PM; Stark ME; Thomas CS; Rivera CE; Wysokinska EM; Chen D
JAMA Cardiol; 2016 May; 1(2):198-204. PubMed ID: 27437891
[TBL] [Abstract][Full Text] [Related]
4. Correction of acquired von Willebrand syndrome by transcatheter aortic valve implantation.
Marggraf O; Schneppenheim S; Daubmann A; Budde U; Seiffert M; Reichenspurner H; Treede H; Blankenberg S; Diemert P
J Invasive Cardiol; 2014 Dec; 26(12):654-8. PubMed ID: 25480995
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter aortic valve implantation leads to a restoration of von Willebrand factor (VWF) abnormalities in patients with severe aortic stenosis - Incidence and relevance of clinical and subclinical VWF dysfunction in patients undergoing transfemoral TAVI.
Sedaghat A; Kulka H; Sinning JM; Falkenberg N; Driesen J; Preisler B; Hammerstingl C; Nickenig G; Pötzsch B; Oldenburg J; Hertfelder HJ; Werner N
Thromb Res; 2017 Mar; 151():23-28. PubMed ID: 28088607
[TBL] [Abstract][Full Text] [Related]
6. Acquired von Willebrand Syndrome Hiding Inherited von Willebrand Disease Can Explain Severe Bleeding in Patients With Aortic Stenosis.
Casonato A; Galletta E; Cella G; Barbon G; Daidone V
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2187-2194. PubMed ID: 32640909
[TBL] [Abstract][Full Text] [Related]
7. von Willebrand factor abnormalities in aortic valve stenosis: Pathophysiology and impact on bleeding.
Casonato A; Sponga S; Pontara E; Cattini MG; Basso C; Thiene G; Cella G; Daidone V; Gerosa G; Pagnan A
Thromb Haemost; 2011 Jul; 106(1):58-66. PubMed ID: 21544311
[TBL] [Abstract][Full Text] [Related]
8. Effects of transcutaneous aortic valve implantation on aortic valve disease-related hemostatic disorders involving von Willebrand factor.
Caspar T; Jesel L; Desprez D; Grunebaum L; Samet H; Trinh A; Petit-Eisenmann H; Kindo M; Ohlmann P; Morel O
Can J Cardiol; 2015 Jun; 31(6):738-43. PubMed ID: 25935884
[TBL] [Abstract][Full Text] [Related]
9. Severe Aortic Valve Stenosis.
Frank RD; Lanzmich R; Haager PK; Budde U
Clin Appl Thromb Hemost; 2017 Apr; 23(3):229-234. PubMed ID: 27481874
[TBL] [Abstract][Full Text] [Related]
10. Rapid Restoration of Thrombus Formation and High-Molecular-Weight von Willebrand Factor Multimers in Patients with Severe Aortic Stenosis After Valve Replacement.
Yamashita K; Yagi H; Hayakawa M; Abe T; Hayata Y; Yamaguchi N; Sugimoto M; Fujimura Y; Matsumoto M; Taniguchi S
J Atheroscler Thromb; 2016 Oct; 23(10):1150-1158. PubMed ID: 27052664
[TBL] [Abstract][Full Text] [Related]
11. Unexpectedly High Prevalence of Acquired von Willebrand Syndrome in Patients with Severe Aortic Stenosis as Evaluated with a Novel Large Multimer Index.
Tamura T; Horiuchi H; Imai M; Tada T; Shiomi H; Kuroda M; Nishimura S; Takahashi Y; Yoshikawa Y; Tsujimura A; Amano M; Hayama Y; Imamura S; Onishi N; Tamaki Y; Enomoto S; Miyake M; Kondo H; Kaitani K; Izumi C; Kimura T; Nakagawa Y
J Atheroscler Thromb; 2015; 22(11):1115-23. PubMed ID: 26269004
[TBL] [Abstract][Full Text] [Related]
12. Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent.
Jilma-Stohlawetz P; Quehenberger P; Schima H; Stoiber M; Knöbl P; Steinlechner B; Felli A; Jilma B
Thromb Res; 2016 Jan; 137():196-201. PubMed ID: 26616301
[TBL] [Abstract][Full Text] [Related]
13. Loss of high-molecular-weight von Willebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis.
Panzer S; Badr Eslam R; Schneller A; Kaider A; Koren D; Eichelberger B; Rosenhek R; Budde U; Lang IM
Thromb Haemost; 2010 Feb; 103(2):408-14. PubMed ID: 20024494
[TBL] [Abstract][Full Text] [Related]
14. Acquired von Willebrand syndrome in aortic stenosis.
Vincentelli A; Susen S; Le Tourneau T; Six I; Fabre O; Juthier F; Bauters A; Decoene C; Goudemand J; Prat A; Jude B
N Engl J Med; 2003 Jul; 349(4):343-9. PubMed ID: 12878741
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease.
Mannucci PM; Capoferri C; Canciani MT
Br J Haematol; 2004 Jul; 126(2):213-8. PubMed ID: 15238142
[TBL] [Abstract][Full Text] [Related]
16. Alteration of von Willebrand Factor after Transcatheter Aortic Valve Replacement in the Absence of Paravalvular Regurgitation.
Pawlitschek F; Keyl C; Zieger B; Budde U; Beyersdorf F; Neumann FJ; Stratz C; Nührenberg TG; Trenk D
Thromb Haemost; 2018 Jan; 118(1):103-111. PubMed ID: 29304530
[TBL] [Abstract][Full Text] [Related]
17. The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI.
Roth N; Heidel C; Xu C; Hubauer U; Wallner S; Meindl C; Holzamer A; Hilker M; Creutzenberg M; Sossalla S; Maier L; Jungbauer C; Debl K
Clin Res Cardiol; 2022 Dec; 111(12):1348-1357. PubMed ID: 35838799
[TBL] [Abstract][Full Text] [Related]
18. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic pathway(s) of acquired von willebrand syndrome with a continuous-flow ventricular assist device: in vitro findings.
Dassanayaka S; Slaughter MS; Bartoli CR
ASAIO J; 2013; 59(2):123-9. PubMed ID: 23438773
[TBL] [Abstract][Full Text] [Related]
20. Impact of loss of high-molecular-weight von Willebrand factor multimers on blood loss after aortic valve replacement.
Bolliger D; Dell-Kuster S; Seeberger MD; Tanaka KA; Gregor M; Zenklusen U; Tsakiris DA; Filipovic M
Br J Anaesth; 2012 May; 108(5):754-62. PubMed ID: 22311365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
